We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$202M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
(+13%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
32,646.26%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.5M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$54.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.9M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$16.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$10.7M |
| 2 |
General Mills
GIS
|
+$5.39M |
| 3 |
Microsoft
MSFT
|
+$3.32M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.24M |
| 5 |
Energizer
ENR
|
+$2.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 28.66% |
| 2 | Technology | 9.15% |
| 3 | Healthcare | 7.9% |
| 4 | Financials | 6.09% |
| 5 | Consumer Discretionary | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Toro Company
TTC
$8.91B
| $659 | 0.1% |
9,941
+9,904
| +26,768% | +$650K |
|
152
iShares Gold Trust
IAU
$62.2B
| $635 | 0.09% |
18,681
+769
| +4% | +$25.2K |
|
153
Vanguard High Dividend Yield ETF
VYM
$79.7B
| $635 | 0.09% |
8,075
-540
| -6% | -$42K |
|
154
Comcast
CMCSA
$84.9B
| $625 | 0.09% |
16,039
+12,290
| +328% | +$468K |
|
155
Ecolab
ECL
$75.6B
| $609 | 0.09% |
3,063
+23
| +0.8% | +$4.45K |
|
156
Wells Fargo
WFC
$261B
| $599 | 0.09% |
23,422
+3,508
| +18% | +$96K |
|
157
Roper Technologies
ROP
$36.6B
| $582 | 0.08% |
1,499
+25
| +2% | +$8.96K |
|
|
RDS.A
158
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $567 | 0.08% |
17,417
+4,973
| +40% | +$171K |
|
159
VanEck Semiconductor ETF
SMH
$67.3B
| $561 | 0.08% |
+35,052
| New | +$2.41M |
|
160
Vail Resorts
MTN
$5.21B
| $559 | 0.08% |
+3,067
| New | +$536K |
|
161
Stryker
SYK
$122B
| $558 | 0.08% |
3,096
+39
| +1% | +$7.19K |
|
162
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
| $553 | 0.08% |
+9,784
| New | +$548K |
|
163
Blackrock
BLK
$163B
| $547 | 0.08% |
1,004
| – | – |
|
164
iShares ESG Aware MSCI USA ETF
ESGU
$17.7B
| $543 | 0.08% |
+7,759
| New | +$511K |
|
165
TotalEnergies
TTE
$180B
| $539 | 0.08% |
14,023
-68,135
| -83% | -$2.52M |
|
166
Cardinal Health
CAH
$52.9B
| $522 | 0.08% |
10,000
-10,301
| -51% | -$531K |
|
167
Rollins
ROL
$21.5B
| $518 | 0.07% |
+18,345
| New | +$491K |
|
168
Ametek
AME
$53.9B
| $517 | 0.07% |
5,785
+76
| +1% | +$6.38K |
|
169
Union Pacific
UNP
$176B
| $507 | 0.07% |
3,001
+39
| +1% | +$6.25K |
|
170
CoStar Group
CSGP
$12.1B
| $493 | 0.07% |
+6,940
| New | +$449K |
|
171
Citigroup
C
$216B
| $487 | 0.07% |
9,538
+6,291
| +194% | +$298K |
|
172
Steris
STE
$20.9B
| $471 | 0.07% |
3,073
+3,033
| +7,583% | +$462K |
|
173
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.34B
| $465 | 0.07% |
21,209
-8,163
| -28% | -$216K |
|
174
Lockheed Martin
LMT
$117B
| $463 | 0.07% |
1,270
+21
| +2% | +$7.93K |
|
175
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.2B
| $462 | 0.07% |
+7,000
| New | +$454K |
|
Similar funds
4FG
BFA
GDADCM
PCMK
CWM
AFWM
HWMO
PCM
tru Independence's Q2 2020 Portfolio in Review
As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.
tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.
By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.
- tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
- tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
- tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
- tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
- tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
- tru Independence opened 207 new positions and closed 53 in Q2 2020.
- tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.
Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.